BioScience Managers invests in CSIRO-derived microencapsulation technology

Melbourne, Australia and London, UK 8 August 2019 – BioScience Managers (BSM), one of Australia’s leading international healthcare investment firms, today announces an investment in Sydney-based nutrition technology company, Pharmamark Nutrition Pty. Ltd. BSM has invested A$5.5 million in Pharmamark Nutrition. The funds will go toward the development of CSIRO’s microencapsulation technology for Pharmamark’s IntEncap™ product […]

Healthcare Investing: Wealth Managers Chart Way Forward

Link to full Article Will Brooks and Jeremy Curnock Cook, 17 April 2019 The healthcare sector has seen huge investment growth and more specialised products starting to emerge. Two specialists navigate what is on offer. Global spending on healthcare is projected to reach $10 trillion by 2022. Venture capital flowing into UK medtech companies has […]

UK biotech industry surges by 65%, giving hope· as Brexit looms

London and Oxbridge ‘Golden Triangle’ retains top position, hosting 1 in 3 biotechs The number of UK  biotechs  has  increased by 65%  in the  last  three years,  according to analysis by London -based investment management firm Downing LLP.  The growth has  been  fueled  by record  levels of investment as the UK biotech industry attracted £2.2 […]

Venture capital biotech funding increases 35% year on year

28 MAR 2019 Link to article Venture capital channels over £2m a day into biotech, accounting for two thirds of all biotech funding Venture capital funding for UK biotechnology has increased by 35 per cent year on year to £182 million in the first quarter of 2019. This compares with £135 million in Q1 2018. […]

BioScience Managers appoints Dr. Kate Rowley as UK-based Investment Director

London, UK and Melbourne, Australia, 30 October 2018 – BioScience Managers Limited (BioScience Managers), the international healthcare investment firm today announces the appointment of Dr. Kate Rowley as Investment Director, based in London. Reflecting BioScience Managers’ international focus Dr. Rowley’s role will be to review and evaluate healthcare investment opportunities and manage investment deals from […]

Downing FOUR VCT invests £1.14 million in ADC Biotechnology Ltd

Investment from Downing FOUR VCT (Healthcare and General share classes) advised by BioScience Managers Limited Funds used to progress development of Antibody Drug Conjugate (ADCs) technology Downing FOUR VCT is targeting dividends of at least 4% p.a. (of net assets) from the fourth year onwards * London, UK, 24 April 2018 – London-based investment management […]

BioScience Managers Expands Team, Adding Significant New International Expertise

London, UK and Melbourne, Australia, 30 October 2017 – Leading healthcare investment specialist BioScience Managers Limited (BioScience Managers), has announced the expansion of its team with the addition of three new directors with broad sector and geographic experience – Dr Michael Perry as a Director, Dennis Purcell as a Director and Senior Expert Advisor, and […]

Canary Medical and BioScience Managers form CHARM Informatics

BioScience Managers commits AUS$10M to new joint venture with Canary Medical to serve as a platform to collect and monetize data from implantable and wearable medical devices. Vancouver, British Columbia, Aug 1, 2017 – Canary Medical (Canary) is pleased to announce the formation of CHARM Informatics Pty Ltd (CHARM), in collaboration with BioScience Managers Pty Ltd […]

BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support Bioscience Managers’ and Downing’s Life Sciences Investments

BioScience Managers Appoints Elizabeth Klein as Investment Consultant in the UK to Support Bioscience Managers’ and Downing’s Life Sciences Investments London, UK and Melbourne, Australia, 31 July 2017 – Leading healthcare investment specialist BioScience Managers Limited (BioScience Managers) announces today that it has appointed Elizabeth Klein as an Investment Consultant, to facilitate BioScience Managers’ UK […]

$500 million fund will help build Australia’s biomedical industry of the future

13 December 2016 Joint media release with the Hon. Sussan Ley MP, Minister for Health and Aged Care. The Turnbull Government is today launching the $500 million Biomedical Translation Fund, established under the government’s National Innovation and Science Agenda, which will help take Australian biomedical discoveries out of the laboratory and to the patient. Three […]